Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maryam Zangi
Institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
Observed institutions:
City Of Hope National Medical Center,
Golestan University,
Iranian Research Organization for Science and Technology,
City of Hope,
Golestan University of Medical Sciences,
Beckman Research Institute,
Southern Illinois University Edwardsville
show all 7
ORCID:
0009-0005-7153-3802
Observed ORCID:
0009-0005-7153-3802
OpenAlex ID:
A5034676812
met1 DNA Methyltransferase Controls TERT Gene Expression: A New Insight to The Role of Telomerase in Development.
2020
·
Maryam Zangi
, Mohammad Bagher Bagherieh Najjar
, et al.
·
PubMed Central
·
8
PDF
Oxa-Michael/Ugi-Smiles cascade reaction with α,β-unsaturated aldehydes
2022
·
Aubrey Thessing
, Robert Ayres
, et al.
·
Results in Chemistry
·
6
PDF
Utility of P19 Gene-Silencing Suppressor for High Level Expression of Recombinant Human Therapeutic Proteins in Plant Cells
2016
·
Maryam Zangi
, Hamideh Ofoghi
, et al.
·
Research in Molecular Medicine
·
5
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
·
Cancer Research Communications
·
3
Association of Interleukin 13/+110 Gene Polymorphism with Hepatitis B Virus Infection in Golestan Province, Northern Iran
2019
·
Maryam Zangi
, Azam Bakhshandeh
, et al.
·
Jundishapur Journal of Microbiology
·
3
PDF
Abstract 6989: Advancing AOH1996: Enhanced anticancer activity of next-generation small molecule PCNA inhibitors
2025
·
Pouya Haratipour
, Maryam Zangi
, et al.
·
Cancer Research
·
2
Data from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
·
1
Second-Generation AOH1996 Analogues with Enhanced Pharmacological Properties for Targeting PCNA
2026
·
Pouya Haratipour
, Maryam Zangi
, et al.
·
Journal of Medicinal Chemistry
Supplemental Figure 4 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Supplemental Figure 5 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Supplemental Figure 6 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 8 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 7 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 3 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Supplemental Figure 2 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 6 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 5 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 2 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 4 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Supplemental Figure 1 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Figure 1 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Supplemental Figure 3 from Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer
2026
·
Sebastian O. Wendel
, Grant M. Brooke
, et al.
Abstract 5140: Development of hydrophilic and metabolically stable heterocyclic AOH1996 analogues for pediatric AML oral liquid formulations
2026
·
Pouya Haratipour
, Melissa Valerio
, et al.
·
Cancer Research
Abstract 6506: Antitumor synergy of AOH1996 and next-generation caPCNA Inhibitors in combination with targeted and chemotherapeutic agents
2026
·
Robert G. Lingeman
, Long Gu
, et al.
·
Cancer Research
Abstract 4481: Enhancing AOH1996 through structure activity relationship exploration for caPCNA inhibition
2024
·
Pouya Haratipour
, Maryam Zangi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
27
Citation count:
28
H-index:
3
I10-index:
Year
Topic
Type